YANET PINO: Open Payments
NPI 1679100820 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 69 payments from 17 companies in 2025. Trend: 2023 $455 · 2024 $1,107 · 2025 $1,491
Food & beverage: $1,491
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $289 |
| Phathom Pharmaceuticals, Inc. | 10 | $267 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $220 |
| Lilly USA, LLC | 7 | $140 |
| Janssen Biotech, Inc. | 5 | $115 |
| Intercept Pharmaceuticals, Inc. | 4 | $83 |
| GENZYME CORPORATION | 3 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| PFIZER INC. | 3 | $51 |
| Madrigal Pharmaceuticals | 2 | $45 |
Products named: VOQUEZNA, RINVOQ, OMVOH, DUPIXENT, ENTYVIO, TREMFYA, OCALIVA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
